Nephros (NEPH) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.72% |
| Dec 31, 2025 | 15.70% |
| Sep 30, 2025 | 17.61% |
| Jun 30, 2025 | 16.05% |
| Mar 31, 2025 | 18.98% |
| Dec 31, 2024 | 31.95% |
| Sep 30, 2024 | 17.08% |
| Jun 30, 2024 | 26.52% |
| Mar 31, 2024 | 36.90% |
| Dec 31, 2023 | 9.71% |
| Sep 30, 2023 | 24.21% |
| Jun 30, 2023 | 16.74% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -40.63% |
| Sep 30, 2022 | -64.38% |
| Jun 30, 2022 | -47.58% |
| Mar 31, 2022 | -71.88% |
| Dec 31, 2021 | 31.95% |
| Sep 30, 2021 | -64.38% |
| Jun 30, 2021 | -43.10% |
| Mar 31, 2021 | -24.57% |
| Dec 31, 2020 | -31.95% |
| Sep 30, 2020 | -43.10% |
| Jun 30, 2020 | -25.93% |
| Mar 31, 2020 | -71.88% |
| Dec 31, 2019 | 12.94% |
| Sep 30, 2019 | -23.81% |
| Jun 30, 2019 | 7.79% |
| Mar 31, 2019 | -1.03% |
| Dec 31, 2018 | -19.14% |
| Sep 30, 2018 | -21.67% |
| Jun 30, 2018 | -14.87% |
| Mar 31, 2018 | -17.41% |
| Dec 31, 2017 | 17.32% |
| Sep 30, 2017 | 32.24% |
| Jun 30, 2017 | 32.24% |
| Mar 31, 2017 | 27.52% |
| Dec 31, 2016 | 30.12% |
| Sep 30, 2016 | 24.21% |
| Jun 30, 2016 | 19.73% |
| Mar 31, 2016 | 35.56% |
| Dec 31, 2015 | -14.96% |
| Sep 30, 2015 | 35.56% |
| Jun 30, 2015 | 19.73% |